Cover2 Resources

Ep. 277 - Rapid Changes to Opioid Treatment Driven by COVID-19

Informações:

Synopsis

Last week, a STAT News article titled “Covid-19 will worsen the opioid overdose crisis if we don’t prepare now,” stated that, “Missing from the national discussion on the coronavirus has been another vulnerable group: patients with opioid use disorder. Despite ongoing public health efforts, the opioid overdose crisis does not appear to be slowing down. The emergency of Covid-19 could worsen it if we do not preemptively develop and implement response plans now.” As we know all too well, social isolation is a key measure for preventing infection and curbing the spread of the virus. Many patients taking medications to treat their opioid use disorder — methadone or buprenorphine — aren’t able to stay home. Government regulations limit how these medications are prescribed and dispensed, often requiring inpatient treatment. Here to talk about what’s being done for those in SUD treatment is Dr. Rick Massatti, the State Opioid Treatment Authority at the Ohio Department of Mental Health and Addiction Services (OhioM